Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Genitourinary 2Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Leukemia, Myeloid, Chronic-Phase 17Leukemia 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Leukemia, Myeloid, Accelerated Phase 5Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycythemia Vera 3Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Hairy Cell 3Hodgkin Disease 3Burkitt Lymphoma 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Therapeutics 6Flow Cytometry 5Psychiatric Rehabilitation 3Immunologic Techniques 3Cyclophosphamide 3Amplified Fragment Length Polymorphism Analysis 3ruxolitinib 2pembrolizumab 2liposomal amphotericin B 2abiraterone 2Vorinostat 2Sirolimus 2Radiotherapy 2Polymerase Chain Reaction 2Ondansetron 2Mycophenolic Acid 2Methylprednisolone 2Itraconazole 2Ipilimumab 2Immunoglobulin G 2Immunoenzyme Techniques 2Gemcitabine 2Doxorubicin 2Disulfides 2Dexamethasone 2Deferasirox 2Caspofungin 2Calcium Dobesilate 2CTLA-4 Antigen 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Interferon-alpha × Myeloid × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡